The five-star questions (marked *****) are:
1, 4, 5, 7, 8, 9, 12, 15, 17, 18, 19, 20, 21, 22, 23
Here are all 15 five-star SAQ answers, fully exam-ready:
⭐⭐⭐⭐⭐ FIVE-STAR SAQs — GENERAL MICROBIOLOGY
(5-Mark Exam Answers)
Q1. Koch's Postulates with Examples
Introduction:
Koch's postulates (1876–1884) are four criteria formulated by Robert Koch to establish a causal relationship between a specific microorganism and a specific disease.
The Four Postulates:
| No. | Postulate |
|---|
| 1 | The suspected microorganism must be present in every case of the disease and absent in healthy individuals |
| 2 | The organism must be isolated from the diseased host and grown in pure culture in vitro |
| 3 | When the pure culture is inoculated into a healthy susceptible host, the same disease must be reproduced |
| 4 | The organism must be re-isolated from the experimentally diseased host and shown to be identical to the original isolate |
Classic Examples:
- Anthrax (Bacillus anthracis) - Koch first proved his own postulates with this organism
- Tuberculosis (Mycobacterium tuberculosis) - 1882, Koch's most famous work
- Cholera (Vibrio cholerae)
Limitations / Modern Exceptions:
| Limitation | Example |
|---|
| Asymptomatic carriers - organism present without disease | V. cholerae, Poliovirus |
| Obligate intracellular pathogens - cannot grow in pure culture | Chlamydia, Rickettsia, all viruses |
| Polymicrobial infections - multiple organisms cause one disease | Periodontal disease |
| Cannot ethically infect humans | HIV, Treponema pallidum |
Molecular Koch's Postulates (Falkow, 1988) updated these criteria for the genomic era - using gene knockout/insertion to prove virulence gene function.
Q4. Dark Field Microscope — Principle & Applications
Introduction:
The dark-field microscope is a modified compound light microscope in which the illumination system is altered so that only oblique rays strike the specimen.
Principle:
- A special dark-field condenser (with a circular opaque disc/stop) blocks all direct light
- Only peripheral oblique rays are allowed to illuminate the specimen from the sides
- These oblique rays do not enter the objective directly
- They enter the objective only if scattered/reflected by the specimen
- Result: specimen appears as bright, luminous objects against a completely dark background
- Can detect organisms as thin as 0.02 µm - far below the resolution of bright-field microscopy (~0.2 µm)
Diagram of Principle:
Light source → Condenser (with central stop) → Oblique rays → Specimen
↓ ↓
Direct light blocked Scattered light enters objective
→ Bright image on dark background
Key Advantage:
Visualizes organisms too thin to stain and too thin to see with conventional microscopy.
Applications:
| Application | Organism | Significance |
|---|
| Diagnosis of Primary Syphilis | Treponema pallidum | Too thin (0.2 µm); corkscrew motility visible; GOLD STANDARD before serology turns positive |
| Leptospirosis | Leptospira interrogans | Hooked ends visible; from urine/CSF |
| Relapsing fever | Borrelia recurrentis | From blood smears |
| Live unstained preparations | Any motile bacteria | Motility assessment, morphology |
| Spirochete identification | Treponema vincenti | Vincent's angina |
Note: Dark-field is the method of choice for diagnosing primary syphilis because serology (VDRL/TPHA) may be negative in early primary syphilis, and T. pallidum cannot be cultured.
Q5. Gram-Positive vs. Gram-Negative Cell Wall — Differentiation with Examples
Introduction:
The Gram stain (Hans Christian Gram, 1884) differentiates bacteria into two groups based on fundamental differences in their cell envelope structure.
Comparison Table:
| Feature | Gram-Positive | Gram-Negative |
|---|
| Gram stain colour | Purple/Violet | Pink/Red |
| Peptidoglycan layer | Thick (20–80 nm; multiple sheets; ~50% of wall dry weight) | Thin (2–7 nm; 1–2 sheets; ~5–10% of wall) |
| Teichoic acids | Present (wall teichoic acid + lipoteichoic acid anchored to membrane) | Absent |
| Outer membrane | Absent | Present (phospholipid bilayer) |
| LPS (Endotoxin) | Absent | Present (Lipid A = endotoxin) |
| Periplasmic space | Absent | Present (contains enzymes: β-lactamase, aminoglycoside-modifying enzymes) |
| Porin proteins | Absent | Present (allow hydrophilic molecule entry) |
| Mesosomes | Present | Less prominent |
| Penicillin sensitivity | Generally more sensitive | Generally less sensitive |
| Lysozyme sensitivity | Yes | No (outer membrane blocks access) |
| Examples | Staphylococcus aureus, Streptococcus pneumoniae, Bacillus anthracis, Clostridium tetani | Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella typhi, Neisseria meningitidis |
Key Structural Components Explained:
Gram-Positive Cell Wall:
- Peptidoglycan backbone: NAG (N-acetylglucosamine) - NAM (N-acetylmuramic acid) repeating units with tetrapeptide side chains cross-linked by pentaglycine bridges (S. aureus) or direct bonds
- Teichoic acids: Glycerophosphate / ribitol phosphate polymers - role in adherence, ion transport, antigenicity
Gram-Negative Cell Wall:
- Thin peptidoglycan in periplasmic space
- Outer membrane: Bilayer with LPS (Lipid A + Core polysaccharide + O-antigen), porins (OmpC, OmpF), and lipoproteins (Braun's lipoprotein anchoring outer membrane to peptidoglycan)
- O-antigen: Highly variable → basis of serotyping (e.g., E. coli O157:H7)
Why Gram-Negative Bacteria are More Resistant to Antibiotics:
The outer membrane acts as a permeability barrier, preventing many antibiotics from reaching their target (peptidoglycan or inner membrane). β-lactamases in the periplasmic space inactivate penicillins before they reach PBPs.
Q7. Bacterial Capsule — Structure, Function & Demonstration
Introduction:
The bacterial capsule is a well-defined, organized, viscous layer of polymer (usually polysaccharide) that lies outside the cell wall and is firmly attached to it. If the layer is loosely attached and diffuse, it is called a slime layer. The collective term is glycocalyx.
Structure / Composition:
| Organism | Capsule Composition | Significance |
|---|
| Streptococcus pneumoniae | Complex polysaccharide (>90 serotypes) | Basis of pneumococcal typing and vaccine |
| Klebsiella pneumoniae | Polysaccharide | Mucoid colonies; K antigen |
| Haemophilus influenzae type b | Polyribitol phosphate | Most virulent type; Hib vaccine target |
| Neisseria meningitidis | Sialic acid polysaccharide | Groups A, B, C, W, Y |
| Bacillus anthracis | Poly-D-glutamic acid polypeptide | Only bacterial capsule that is a polypeptide (not polysaccharide) |
| Cryptococcus neoformans | Large polysaccharide capsule (fungus) | Detected by India ink in CSF |
Functions:
- Anti-phagocytic - Most important virulence function. Hydrophilic capsule repels phagocytes (which have hydrophobic surfaces). Loss of capsule = loss of virulence (e.g., smooth → rough S. pneumoniae)
- Complement evasion - Interferes with C3b deposition; poorly activates complement
- Adhesion - Mediates attachment to host tissues and prosthetic devices (biofilm). S. mutans uses dextran/levan capsule to adhere to tooth enamel
- Desiccation resistance - Capsule is highly hydrated; protects from drying
- K antigen - Highly antigenic; basis for vaccine development (pneumococcal, meningococcal, Hib polysaccharide conjugate vaccines)
Demonstration Methods:
| Method | Principle | Result |
|---|
| Negative staining (India ink / Nigrosin) | Background stains dark; capsule excludes ink particles; cell stains | Clear halo around dark background and stained cell (most commonly used) |
| Quellung reaction (Neufeld's test) | Type-specific anti-capsular antibody + organism → capsule appears to swell/become refractile under light microscopy | Used for S. pneumoniae serotyping (capsule "swells" - actually becomes more visible) |
| Anthony's method | Crystal violet (primary) + 20% CuSO₄ (mordant/decolorizer instead of water) | Capsule: pale blue; Cell: dark blue/purple |
| Welch method | Hot crystal violet + copper sulphate rinse | Capsule pale, cells dark |
Key fact: Encapsulated organisms produce smooth (S) colonies (mucoid, glistening). Non-capsulated = rough (R) colonies (dull, irregular). Smooth strains are virulent; rough strains are avirulent.
Q8. Bacterial Spores — Types, Function, Examples & Demonstration
Introduction:
Bacterial endospores are small, dehydrated, metabolically dormant survival structures produced intracellularly by certain Gram-positive bacteria under adverse conditions (nutrient deprivation). They are NOT reproductive structures — one cell forms one spore → one spore germinates into one cell.
Characteristics:
- Resistant to: boiling, autoclaving (destroyed only at 121°C/15 psi/15 min), disinfectants, UV radiation, desiccation, extreme pH
- Viable for decades to centuries
- Killed by dry heat at 160–170°C for 1–2 hours
Structure (Layers from inside out):
| Layer | Composition | Function |
|---|
| Core | DNA, ribosomes, enzymes, calcium dipicolinate (5–15% dry wt), no ATP, minimal water | Dormant metabolic unit; heat resistance |
| Spore wall | Normal peptidoglycan | Becomes vegetative cell wall on germination |
| Cortex | Modified peptidoglycan (fewer cross-links); thick | Heat resistance; maintains dehydration |
| Spore coat | Keratin-like protein with disulfide bonds; multilayered | Resistance to chemicals, enzymes |
| Exosporium | Glycoprotein layer (in some spp.) | Present in B. anthracis, B. cereus |
Position within Cell and Examples:
| Position | Appearance | Examples |
|---|
| Central | Spore at center; no distension | B. anthracis, B. subtilis, B. cereus |
| Subterminal | Near end; no distension | C. perfringens, C. botulinum (spindle-shaped) |
| Terminal | At pole; no distension | B. sphaericus |
| Terminal (drumstick) | At pole; cell distended | C. tetani - classic drumstick appearance |
Clinically Important Spore-Forming Bacteria:
| Organism | Disease |
|---|
| Clostridium tetani | Tetanus |
| Clostridium botulinum | Botulism |
| Clostridium perfringens | Gas gangrene, food poisoning |
| Clostridium difficile | Pseudomembranous colitis (AAD) |
| Bacillus anthracis | Anthrax (bioterrorism agent) |
| Bacillus cereus | Food poisoning |
Sporulation (triggered by nutrient depletion):
7 stages: Axial filament → Membrane septum → Forespore engulfment → Cortex synthesis → Coat synthesis → Maturation → Release
Germination (3 stages):
- Activation - Heat, abrasion, acid
- Initiation - Germinant (L-alanine, adenosine) triggers cortex lysis → water influx, Ca²⁺-dipicolinate release
- Outgrowth - New vegetative cell emerges with active biosynthesis
Demonstration / Staining:
| Method | Stain | Result |
|---|
| Schaeffer-Fulton (most common) | Malachite green (heated, primary) + Safranin (counterstain) | Spores: Green; Vegetative cells: Red |
| Modified ZN stain | Carbol fuchsin + 1% H₂SO₄ decolorizer | Spores stain like acid-fast organisms |
| Unstained preparations | None | Spores appear as bright refractile bodies |
Q9. Bacterial Growth Curve
Introduction:
The bacterial growth curve is a graphical representation of log (viable count) vs. time when bacteria are grown in a closed batch culture system. It has four distinct phases.
The Four Phases:
| Phase | Growth Rate | Duration | Key Events |
|---|
| 1. Lag Phase | Zero (no cell division) | Minutes to hours | Metabolic adaptation; enzyme synthesis; DNA replication prep; cell enlargement. Duration depends on: inoculum age, medium composition |
| 2. Log (Exponential) Phase | Maximum, constant | Hours | Binary fission at maximum rate for that organism/medium; N = N₀ × 2ⁿ; cells most susceptible to antibiotics; most uniform population |
| 3. Stationary Phase | Zero (growth = death) | Hours to days | Nutrient depletion + toxic metabolite accumulation; total count constant; sporulation begins; secondary metabolite production; antibiotic production |
| 4. Death (Decline) Phase | Negative (exponential death) | Days | Cell death exceeds growth; exponential die-off S = S₀e^(-kt); VBNC (viable but non-culturable) cells may persist |
Important Formulae:
- Generation time (g) = t / n (where n = number of generations)
- Number of generations: n = (log N - log N₀) / log 2 = 3.3 × log (N/N₀)
- E. coli generation time = ~20 minutes (fastest)
- M. tuberculosis generation time = ~14–20 hours (slow → explains long treatment duration)
Growth Curve Diagram:
Log viable count
| ___________
| / \
| / \
|_________________/ \___________
|←—Lag—→|←———Log (Exponential)———→|←Stat→|←Death→
Time →
Clinical Relevance:
- Log phase cells - most sensitive to antibiotics targeting cell wall synthesis (penicillin, vancomycin) and protein synthesis
- Stationary phase - antibiotic tolerance; biofilm formation common
- Chemostat - maintains cells in continuous exponential phase by adding fresh medium and removing spent medium; used in research and fermentation
- VBNC phenomenon - clinically important; explains persistent infections (e.g., V. cholerae in water)
Q12. Anaerobic Culture Methods & Media
Introduction:
Anaerobic bacteria cannot grow in the presence of atmospheric O₂ because they lack superoxide dismutase and catalase - leading to accumulation of toxic superoxide radicals (O₂⁻) and H₂O₂.
Classification of Anaerobes:
- Obligate anaerobes - O₂ is lethal (e.g., Bacteroides, Clostridium)
- Aerotolerant anaerobes - O₂ present but not used (e.g., Lactobacillus)
- Microaerophiles - grow best at 5% O₂ (e.g., Campylobacter, H. pylori)
Methods to Achieve Anaerobiosis:
| Method | Mechanism | Notes |
|---|
| 1. GasPak Jar (BBL) | Sachet generates H₂ + CO₂; palladium catalyst: H₂ + O₂ → H₂O; methylene blue indicator turns colorless | Most commonly used; simple; holds several plates |
| 2. Anaerobic Glove Box / Chamber | Large sealed chamber with N₂/H₂/CO₂ gas mix; palladium catalysts; all work done inside | Best method; most expensive; used in reference labs |
| 3. Anaerobic Bio-Bag | Small transparent plastic bag with self-contained gas generator; one plate per bag | Convenient; used for urgent single specimens |
| 4. Candle Jar | Burning candle consumes O₂; 5–10% CO₂ produced → microaerophilic only, NOT anaerobic | Used for N. gonorrhoeae, Campylobacter |
| 5. Thioglycollate broth | Chemical reducing agent (thioglycollate) consumes O₂; resazurin indicator | Liquid medium; anaerobes grow at bottom |
| 6. Roll-tube (Hungate) method | Tubes pre-reduced with CO₂; all transfers done under gas flow | Most stringent; research use |
| 7. Physical methods | Pyrogallol + NaOH absorbs O₂ in sealed containers | Less reliable |
Anaerobic Culture Media:
| Medium | Type | Use |
|---|
| Pre-reduced Blood Agar (PRAS) | Non-selective enriched | All anaerobes |
| Brucella Blood Agar + Vitamin K + Hemin | Non-selective enriched | CDC standard for anaerobes |
| Bacteroides Bile Esculin (BBE) Agar | Selective + differential | B. fragilis group (bile-resistant; esculin hydrolysis → black colonies) |
| Kanamycin-Vancomycin Blood Agar (KVLB) | Selective | Bacteroides, Prevotella (aminoglycosides inhibit aerobes; vancomycin inhibits G+ve aerobes) |
| CCFA (Cycloserine-Cefoxitin Fructose Agar) | Selective | Clostridium difficile (yellow colonies; horse manure odour; fluorescent UV) |
| Thioglycollate broth | Liquid enrichment | All anaerobes; transport medium |
| Cooked Meat Medium (Robertson's) | Liquid enrichment | Clostridium spp.; contains reducing factors |
Incubation:
- Temperature: 35–37°C
- Duration: Minimum 48 hours; hold plates for 5–7 days before reporting negative
- Plates must not be exposed to air during incubation
Clinically Important Anaerobes:
Bacteroides fragilis (most common), Clostridium spp., Fusobacterium, Peptostreptococcus, Prevotella
Q15. Antibiotic Susceptibility Testing (AST) — Classification & Applications
Introduction:
Antibiotic Susceptibility Testing (AST) determines whether a pathogen is susceptible, intermediate, or resistant to an antibiotic, guiding selection of effective therapy.
Classification of AST Methods:
A. Phenotypic Methods:
| Method | Type | Principle | Output |
|---|
| Disc Diffusion (Kirby-Bauer) | Qualitative | Antibiotic disc on Mueller-Hinton Agar; zone of inhibition | S / I / R |
| Broth Microdilution | Quantitative | Serial antibiotic dilutions in wells; observe growth | MIC value (µg/mL) |
| Agar Dilution | Quantitative | Serial antibiotic dilutions in agar; observe growth | MIC value |
| E-test (Epsilometer test) | Quantitative | Plastic strip with antibiotic gradient; MIC read at ellipse intersection | Precise MIC value |
| MBC (Minimum Bactericidal Concentration) | Bactericidal | Subculture from MIC tubes onto antibiotic-free media; lowest conc. killing 99.9% | MBC value |
| Automated systems (VITEK-2) | Quantitative | Fluorimetric/turbidimetric detection in mini-wells | MIC + ID |
B. Molecular / Genotypic Methods:
| Method | Target | Use |
|---|
| PCR | Resistance genes (mecA, vanA, bla-KPC, NDM) | MRSA, VRE, carbapenemase detection |
| Microarray / Hybridization | Multiple resistance genes | Broad panel |
| Whole Genome Sequencing (WGS) | Entire genome | Epidemiology; predicts all resistance |
| MALDI-TOF | Protein fingerprint | Rapid ID (not direct AST, but guides therapy) |
Interpretive Categories (CLSI / EUCAST):
| Category | Abbreviation | Clinical Meaning |
|---|
| Susceptible | S | Standard therapy likely effective |
| Intermediate | I | Use at higher dose or at concentrated site (e.g., UTI) |
| Resistant | R | Standard therapy will likely fail; use alternative |
Key Definitions:
- MIC (Minimum Inhibitory Concentration) - Lowest concentration of drug that inhibits visible growth after 18–24 h
- MBC (Minimum Bactericidal Concentration) - Lowest concentration that kills ≥99.9% of organisms
- Bacteriostatic - MBC/MIC ratio >4
- Bactericidal - MBC/MIC ratio ≤4
Applications:
- Guide individual patient therapy - Choice and dose of antibiotic
- Detect resistant organisms - MRSA, VRSA, ESBL, CRE, MDR-TB
- Hospital infection control - Track antibiogram trends; isolate resistant strains
- Antimicrobial stewardship - Prevent overuse; rotate antibiotics
- New drug development - Breakpoint determination
- Epidemiological surveillance - WHO/CDC monitoring of resistance patterns
Q17. PCR and Its Applications
Introduction:
Polymerase Chain Reaction (PCR), developed by Kary Mullis (1983, Nobel Prize 1993), is an in-vitro nucleic acid amplification technique that exponentially amplifies a specific DNA sequence using thermocycling.
Principle — Three Steps (One Cycle):
| Step | Temperature | Time | Event |
|---|
| 1. Denaturation | 94–95°C | 30–60 sec | dsDNA strands separate |
| 2. Annealing | 50–65°C | 30–60 sec | Specific primers bind to complementary sequences on each strand |
| 3. Extension | 72°C | 1 min/kb | Taq polymerase synthesizes new strand 5'→3' |
- Each cycle doubles the target DNA
- 30 cycles → ~10⁶-fold (2³⁰ ≈ 10⁹) amplification from a single copy
- Products detected by gel electrophoresis or fluorescence
Key Components:
- Template DNA (target)
- Two primers (short oligonucleotides, 18–25 bp; flank the target)
- Taq polymerase (thermostable; from Thermus aquaticus)
- dNTPs (building blocks)
- MgCl₂ (cofactor for polymerase)
- Buffer
PCR Variants:
| Variant | Principle | Application |
|---|
| RT-PCR | RNA → cDNA (reverse transcriptase) → PCR | RNA virus detection: SARS-CoV-2, HIV, HCV, influenza |
| Real-time (qPCR) | Fluorescent dye/probe detects amplification during cycling | Quantification: HIV viral load, HCV load, BCR-ABL |
| Nested PCR | Two rounds; outer then inner primer pairs | Increased sensitivity/specificity for low-copy targets |
| Multiplex PCR | Multiple primer pairs in one tube | Simultaneous detection of multiple pathogens (respiratory panel) |
| LAMP | Isothermal; 4–6 primers; no thermocycler | Point-of-care diagnostics; resource-limited settings |
| Digital PCR | Partitioning into thousands of wells; absolute quantification | Ultra-sensitive viral load measurement |
| Allele-specific PCR | Primers match one allele only | Single nucleotide polymorphism (SNP) detection |
Applications in Clinical Microbiology:
| Category | Application | Example |
|---|
| Viral diagnosis | Detection of non-culturable viruses; viremia | SARS-CoV-2, HIV, HSV encephalitis (CSF PCR) |
| Bacterial diagnosis | Fastidious/slow-growing organisms | MTB in sputum; Chlamydia, N. gonorrhoeae (NAAT) |
| Drug resistance | Resistance gene detection | mecA (MRSA), vanA (VRE), bla-KPC, rpoB (rifampin resistance) |
| Parasitology | Species differentiation | Plasmodium species; Leishmania; T. cruzi |
| Epidemiology | Strain typing | Outbreak investigation; RFLP; WGS |
| Oncology | Translocation/mutation detection | BCR-ABL (CML), KRAS mutations |
| Blood bank | Pathogen screening in donations | HIV, HCV, HBV, WNV NAT screening |
Advantages over Culture:
- Detects non-culturable organisms
- Results in hours vs. days/weeks
- Extremely sensitive (single copy detection)
- Safe (no live organisms)
Limitations:
- Cannot distinguish live from dead organisms
- Contamination → false positives
- Unknown pathogens missed (unless broad-range 16S PCR)
- Does not provide antibiotic susceptibility
Q18. Transduction
Introduction:
Transduction is the transfer of bacterial DNA from one bacterium (donor) to another (recipient) mediated by a bacteriophage (bacterial virus) acting as a vector.
Mechanism:
- A bacteriophage infects a donor bacterium and replicates inside
- During packaging of phage DNA into capsid, a fragment of bacterial chromosomal DNA is accidentally packaged instead of (or along with) phage DNA
- The resulting transducing phage particle injects this bacterial DNA into a recipient bacterium
- The transferred DNA is incorporated into the recipient chromosome by recombination
Types of Transduction:
| Feature | Generalized Transduction | Specialized Transduction |
|---|
| Phage type | Lytic (e.g., P1 of E. coli) | Temperate lysogenic phage (e.g., λ phage) |
| Mechanism | Random packaging of any bacterial DNA fragment | Imprecise excision of prophage carries adjacent host genes |
| DNA transferred | Any bacterial gene (random) | Only genes adjacent to phage integration site |
| Integration site | Random in chromosome | Fixed (att site) |
| Example | P1 phage transduction of E. coli | λ phage carries gal (galactose) or bio (biotin) genes |
| Frequency | Low (1 in 10⁷–10⁸) | Higher for specific genes near integration site |
Phage Life Cycles Relevant to Transduction:
Lytic cycle: Phage → infects cell → replicates → lyses cell → releases new phages (including transducing particles)
Lysogenic cycle: Phage DNA integrates into host chromosome as prophage → replicates with host → may excise (spontaneously or by UV) → enters lytic cycle
Clinical Significance (Most Important for Exam):
| Organism | Phage-Encoded Virulence Factor |
|---|
| Vibrio cholerae | Cholera toxin (CTX phage) + Toxin-coregulated pili (VPI phage) |
| Corynebacterium diphtheriae | Diphtheria toxin (β-phage) |
| Clostridium botulinum | Botulinum toxin (types C and D) |
| Streptococcus pyogenes | Erythrogenic toxins (scarlet fever; phage-encoded) |
| S. aureus | Some virulence factors (pathogenicity islands) |
| E. coli O157:H7 | Shiga toxin (Stx phage) |
Key point: Many major bacterial virulence factors are phage-encoded and spread by transduction - this is how new pathogenic strains emerge.
Q19. Conjugation
Introduction:
Conjugation is the direct, cell-to-cell transfer of DNA from a donor (F⁺/Hfr) bacterium to a recipient (F⁻) bacterium via physical contact and a conjugal pore formed by the sex pilus (encoded by the F plasmid). It is the most important mechanism for horizontal transfer of antibiotic resistance in clinical settings.
F Plasmid (Fertility Factor):
- Circular, 94.5 kb DNA
- Encodes sex pilus (F pilus) and all transfer functions (~40 genes)
- Cells with F plasmid = F⁺ (male/donor)
- Cells without F plasmid = F⁻ (female/recipient)
Mechanism:
- F⁺ cell synthesizes F pilus (Type IV secretion system)
- F pilus contacts F⁻ cell surface and retracts, bringing cells into close contact
- A mating junction/pore forms between the two cells
- A plasmid-encoded relaxase enzyme nicks the F plasmid at oriT (origin of transfer)
- Rolling circle replication begins - one strand is transferred 5'→3' into recipient
- Complementary strand synthesized in both cells simultaneously
- Both cells end up with complete F plasmid → F⁻ becomes F⁺
Types of Conjugal Transfer:
| Donor Type | Mechanism | Result | Notes |
|---|
| F⁺ × F⁻ | F plasmid transferred alone | F⁻ → F⁺ | Most common; chromosome rarely transferred |
| Hfr (High frequency recombination) × F⁻ | F integrated into chromosome; chromosomal DNA transferred from origin of insertion | Recipient gets chromosomal genes; usually stays F⁻ (F factor last to transfer, rarely complete) | Used for chromosome mapping |
| F' (F-prime) × F⁻ | Excised F plasmid carries chromosomal genes (merodiploid creation) | Recipient has 2 copies of some genes (merodiploid) | Used to study complementation |
| R plasmid (resistance plasmid) | R plasmid transfers via conjugation | Recipient becomes antibiotic resistant | Most clinically important |
R Plasmids (Resistance Plasmids):
- Carry multiple antibiotic resistance genes (encoded by transposons)
- Transfer rapidly between strains, species, and genera
- Clinically important: spread of MDR organisms in hospitals
- Example: E. faecalis transferred vancomycin resistance transposon to S. aureus in co-infected patient → VRSA
Differences from Transformation and Transduction:
| Feature | Transformation | Transduction | Conjugation |
|---|
| DNA source | Naked DNA from environment | Bacteriophage-mediated | Direct cell contact |
| Cell contact required | No | No | Yes |
| Vector | None | Bacteriophage | F plasmid (sex pilus) |
| Size of DNA transferred | Small fragments | Phage head size | Largest - entire plasmid/chromosome |
Clinical Significance:
- Primary mechanism of MDR spread in clinical settings
- Responsible for outbreaks of MDR Klebsiella, ESBL E. coli, CRE
- Drives plasmid-mediated resistance to carbapenems (NDM, KPC), fluoroquinolones (qnr genes), and polymyxins (mcr genes)
Q20. Mechanisms of Drug Resistance
Introduction:
Antibiotic resistance is the ability of bacteria to survive and multiply in the presence of antibiotics that previously inhibited them. Resistance can be intrinsic (naturally present) or acquired (mutation or gene transfer).
Genetic Basis:
| Type | Mechanism | Examples |
|---|
| Chromosomal mutation | Spontaneous point mutation in drug target gene | Rifampin resistance (rpoB mutation); fluoroquinolone resistance (gyrA/parC) |
| Plasmid-mediated | R plasmids transferred by conjugation | β-lactamase genes; aminoglycoside resistance; MDR |
| Transposons | Mobile genetic elements insert resistance genes | Tn3 (ampicillin); Tn10 (tetracycline); vancomycin resistance transposons |
| Integrons | Gene capture systems collecting resistance cassettes | Class 1 integrons in Gram-negative MDR organisms |
Three Major Biochemical Mechanisms:
1. Reduced Drug Accumulation (Exclusion)
a) Reduced uptake:
- Outer membrane porin mutations reduce drug entry (Gram-negative)
- Example: Loss of OprD porin in P. aeruginosa → carbapenem resistance
b) Active efflux pumps:
- Membrane proteins pump drug out of cell before it reaches target
- Example: MexAB-OprM pump in P. aeruginosa (fluoroquinolones, β-lactams)
- TetA efflux pump → tetracycline resistance
- NorA pump in S. aureus → fluoroquinolone resistance
2. Alteration of Drug Target
| Antibiotic Class | Target | Resistance Mechanism | Organism |
|---|
| β-Lactams | Penicillin-binding proteins (PBPs) | mecA gene → PBP2a (low β-lactam affinity) | MRSA |
| Vancomycin | D-Ala-D-Ala terminus | D-Ala-D-Ala → D-Ala-D-Lac substitution (vanA/B genes) | VRE |
| Fluoroquinolones | DNA gyrase (GyrA), Topoisomerase IV (ParC) | Point mutations in QRDR regions | E. coli, S. aureus, N. gonorrhoeae |
| Rifampin | RNA polymerase β subunit (RpoB) | rpoB gene mutation | M. tuberculosis |
| Macrolides/Lincosamides | 23S rRNA (50S ribosome) | Methylation of rRNA (erm genes) | S. aureus, S. pneumoniae |
| Aminoglycosides | 30S ribosome (16S rRNA) | Methylation of 16S rRNA (RMT genes) | MDR Gram-negatives |
3. Enzymatic Inactivation of Antibiotic
| Enzyme | Antibiotic Inactivated | Clinical Example |
|---|
| β-Lactamases (TEM, SHV) | Penicillins | E. coli, Klebsiella |
| ESBL (Extended-Spectrum β-Lactamase) | All penicillins + cephalosporins | ESBL E. coli, ESBL Klebsiella |
| Carbapenemases (KPC, NDM, OXA-48) | All β-lactams incl. carbapenems | CRE (Carbapenem-Resistant Enterobacterales) |
| Aminoglycoside-modifying enzymes (AAC, ANT, APH) | Aminoglycosides (gentamicin, amikacin) | P. aeruginosa, Enterococcus |
| Chloramphenicol acetyltransferase (CAT) | Chloramphenicol | Salmonella, H. influenzae |
Multidrug Resistance (MDR):
- MDR = non-susceptible to ≥1 agent in ≥3 antibiotic categories
- XDR = non-susceptible to all but ≤2 categories
- PDR = non-susceptible to ALL antibiotics
Q21. Exotoxin vs. Endotoxin — Differentiation with Examples
Introduction:
Bacterial toxins are virulence factors that damage host tissues and cause disease. They are broadly classified into exotoxins and endotoxins based on their origin, chemistry, and mechanisms.
Comparison Table:
| Feature | Exotoxin | Endotoxin |
|---|
| Chemical nature | Protein (polypeptide) | Lipopolysaccharide (LPS; Lipid A is the toxic moiety) |
| Source organisms | Both Gram-positive AND Gram-negative | Gram-negative bacteria only (structural cell wall component) |
| Release | Secreted actively during bacterial growth | Released only on bacterial death and lysis |
| Heat stability | Heat-labile (destroyed at 60–80°C/30 min) | Heat-stable (withstands 250°C/30 min) |
| Toxicity | Extremely high (lethal in nanogram to microgram quantities) | Lower; requires larger amounts (microgram quantities) |
| Antigenicity | Highly antigenic | Weakly antigenic |
| Toxoid formation | Yes (detoxified with formalin; used in vaccines - DPT, tetanus) | No (cannot form toxoid) |
| Mechanism | Specific cell receptor binding; enzymatic activity | Activates TLR-4/CD14 on macrophages → cytokine storm (TNF, IL-1, IL-6) |
| Systemic effects | Tissue-specific (nerve, gut, cardiac) | Fever, DIC, hypotension, septic shock |
| Fever production | Usually indirect | Yes (potent pyrogen via IL-1, PGE₂) |
| Gene location | Plasmid or phage-encoded (often) | Chromosomal (structural) |
| Complement activation | Usually not | Yes (alternative pathway) |
Exotoxin Types with Examples:
| Type | Toxin | Organism | Mechanism | Disease |
|---|
| A-B toxin (2-subunit) | Cholera toxin | Vibrio cholerae | B subunit binds GM1 receptor; A subunit ADP-ribosylates Gs protein → permanent ↑adenylate cyclase → ↑cAMP → Cl⁻/water secretion | Rice-water diarrhea |
| A-B toxin | Diphtheria toxin | C. diphtheriae (β-phage) | Inhibits protein synthesis by ADP-ribosylation of EF-2 (elongation factor) | Diphtheria; myocarditis; neuropathy |
| A-B toxin | Botulinum toxin | C. botulinum | Cleaves SNARE proteins → blocks ACh release at NMJ | Flaccid paralysis; botulism |
| A-B toxin | Tetanus toxin (Tetanospasmin) | C. tetani | Transported retrograde to spinal cord; cleaves SNARE → blocks inhibitory neurotransmitter (GABA, glycine) release | Spastic paralysis; tetanus |
| Cytolytic/Cytotoxic | α-toxin (phospholipase C) | C. perfringens | Cleaves phospholipids in cell membrane | Gas gangrene; hemolysis |
| Cytolytic | Streptolysin O/S | S. pyogenes | Pore-forming; lyses RBCs, WBCs | Hemolysis; tissue damage |
| Superantigen | TSST-1 (Toxic Shock Syndrome Toxin-1) | S. aureus | Cross-links MHC II + TCR non-specifically → massive T-cell activation → cytokine storm | Toxic Shock Syndrome (TSS) |
| Superantigen | Exfoliatin (ETA, ETB) | S. aureus | Cleaves desmoglein-1 (skin adhesion protein) | Scalded Skin Syndrome (SSSS) |
Endotoxin — Lipopolysaccharide (LPS) Structure:
- Lipid A (attached to outer membrane) = toxic moiety (causes fever, septic shock)
- Core polysaccharide (R antigen) = structural backbone
- O-antigen (polysaccharide chains) = highly variable; used for serotyping (O157, O139)
Endotoxin Effects (Dose-Dependent):
| Dose | Effect |
|---|
| Low | Fever, leukocytosis, complement activation, immune stimulation (protective) |
| High | Sepsis, DIC (disseminated intravascular coagulation), hypotension, septic shock, death |
Pathophysiology of Endotoxin Shock:
LPS binds LBP (LPS-binding protein) → LPS-LBP complex binds CD14 on macrophages → activates TLR-4 → NFκB activation → massive release of TNF-α, IL-1, IL-6, IL-12 → vasodilation, increased vascular permeability, DIC → septic shock
Q22. Laboratory Diagnosis of Viral Infections
Introduction:
Viral diagnosis uses four complementary approaches: (1) Direct detection, (2) Viral culture, (3) Serological methods, and (4) Molecular methods.
1. Specimen Collection:
| Clinical Syndrome | Specimen |
|---|
| Respiratory infection | Nasopharyngeal swab/aspirate, BAL |
| CNS infection (encephalitis/meningitis) | CSF |
| Viremia (systemic) | EDTA blood (for PCR), serum (for serology) |
| Cutaneous lesions (HSV, VZV) | Vesicle fluid, lesion scraping |
| Gastroenteritis | Stool/rectal swab |
| Hepatitis | Serum |
| Genital infection | Urethral/cervical swab |
| Congenital | Urine (CMV), blood |
All specimens transported in Viral Transport Medium (VTM) on ice. Process promptly.
2. Direct Detection Methods:
| Method | Principle | Organisms/Use |
|---|
| Electron Microscopy (EM) | Negative staining; morphology-based identification | Rotavirus, Norovirus, Poxvirus (historically); research |
| Direct Immunofluorescence (DFA) | Fluorescent-labelled antibody applied directly to specimen/cells | RSV, Influenza A/B, Parainfluenza, Adenovirus, HSV (rapid; from NPA cells) |
| Antigen Detection ELISA | Antigen-antibody sandwich ELISA | Rotavirus (stool), HBsAg (hepatitis B), HCV core Ag, Influenza (rapid Ag test), COVID-19 Ag |
| Cytology | Tzanck smear - multinucleated giant cells + intranuclear inclusions | HSV, VZV (low sensitivity; quick bedside test) |
| Light microscopy - inclusion bodies | Characteristic histological changes | CMV (owl-eye inclusions), Rabies (Negri bodies), Poxvirus (Guarnieri bodies) |
3. Viral Culture (Gold Standard):
Inoculation into:
- Cell lines: Vero (HSV), MDCK (influenza), HEp-2 (RSV), MRC-5 (CMV, VZV)
- Embryonated eggs: Influenza (allantoic cavity), Poxviruses (chorioallantoic membrane)
- Laboratory animals: Only for special viruses (suckling mice for arboviruses)
Evidence of viral growth:
| Evidence | Virus |
|---|
| Cytopathic Effect (CPE) | Cell rounding, syncytia (RSV, HSV), ballooning, sheet detachment |
| Hemadsorption | Influenza, Parainfluenza, Mumps (hemagglutinin on cell surface binds RBCs) |
| Plaque formation | Poliovirus, HSV (clear plaques in cell monolayer) |
| Interference | Virus present but no CPE; detected by inhibiting indicator virus |
| Transformation | Oncogenic viruses (EBV, HPV, HTLV-1) |
4. Serology:
| Method | Use |
|---|
| IgM detection (ELISA) | Acute/primary infection (IgM = recent); CMV, EBV, HAV, rubella, measles |
| IgG seroconversion (4-fold rise in paired sera 2–4 weeks apart) | Retrospective confirmation |
| Western Blot (WB) | HIV confirmatory test (bands to gp120, gp41, p24) |
| Complement Fixation (CF) | Older method; 4-fold rise = significant |
| PRNT (Plaque Reduction Neutralisation Test) | Gold standard for arbovirus serology |
| Widal test | Agglutination (Salmonella - technically bacterial) |
5. Molecular Methods (Most Sensitive & Specific):
| Method | Use |
|---|
| PCR / RT-PCR | Method of choice for most viral pathogens; detects viral nucleic acid |
| Real-time qPCR | Quantification: HIV viral load, HCV viral load, CMV monitoring in transplant |
| Multiplex PCR panel | FilmArray respiratory panel - detects 20+ pathogens simultaneously |
| NASBA | Isothermal RNA amplification; HIV, CMV |
| bDNA (branched DNA) | Signal amplification for HCV/HIV quantification |
| Next-generation sequencing (NGS/WGS) | Unknown pathogen identification; resistance genotyping |
Summary — Method of Choice by Pathogen:
| Virus | Best Diagnostic Method |
|---|
| SARS-CoV-2 | RT-PCR (NPS swab) |
| HIV | 4th-gen ELISA (Ag/Ab combo) → WB confirmatory; VL by PCR |
| HCV | Anti-HCV ELISA → HCV RNA PCR (quantitative) |
| HBV | HBsAg + HBeAg + Anti-HBc IgM + HBV DNA PCR |
| CMV | PP65 antigenemia OR CMV DNA PCR (blood/urine) |
| HSV encephalitis | CSF HSV PCR (gold standard) |
| Influenza | Rapid Ag test (bedside) OR RT-PCR |
| Rotavirus | Stool ELISA antigen detection |
| Rabies | DFA on brain tissue; DFA on skin biopsy (nape of neck) |
Q23. Tissue Culture — Methods & Applications
Introduction:
Tissue culture (cell culture) is the in-vitro maintenance and growth of cells, tissues, or organs in a controlled sterile environment. It is the gold standard for viral isolation and has broad research and industrial applications.
Systems for Virus Propagation (in order of complexity):
1. Laboratory Animals
- Suckling mice (inoculated intracerebrally) - arboviruses, rabies
- Guinea pigs, rabbits - older methods
- Now largely replaced by cell culture for routine diagnosis
2. Embryonated Hen's Eggs
- Allantoic cavity - Influenza A/B, Mumps (large volumes; vaccine production)
- Amniotic cavity - Influenza A (primary isolation)
- Chorioallantoic membrane (CAM) - Vaccinia, HSV, Poxviruses (visible pocks)
- Yolk sac - Chlamydia, Rickettsia, some arboviruses
3. Cell / Tissue Culture (Most Important)
Types of Cell Lines:
| Type | Characteristics | Examples | Viruses Grown |
|---|
| Primary cell cultures | Freshly prepared from animal/human tissue; finite life (1–2 passages); normal diploid; most sensitive | Primary monkey kidney (PMK), primary human embryonic kidney (HEK) | Poliovirus, Adenovirus, Influenza (PMK) |
| Diploid (semi-continuous) cell lines | Normal human fibroblasts; limited to 50–80 passages before senescence | WI-38 (human lung), MRC-5 (human fetal lung) | CMV, VZV, Rubella, HSV, Adenovirus |
| Continuous (heteroploid) cell lines | Immortalized (tumor-derived or spontaneously transformed); infinite passage; aneuploid | Vero (African green monkey kidney), HEp-2 (human laryngeal carcinoma), HeLa (human cervical carcinoma), MDCK (Madin-Darby canine kidney), BGM | HSV (Vero), RSV (HEp-2), Influenza (MDCK), Enteroviruses |
Shell Vial Culture (Modified Centrifugation-Enhanced Culture):
- Specimen centrifuged onto monolayer → DFA at 24–48 h → faster than conventional culture (days vs. weeks)
- Used for: CMV (HEL cells + CMV early antigen DFA; result in 16–24 h vs. 4 weeks), HSV
Evidence of Viral Growth in Culture:
| Evidence | Description | Examples |
|---|
| Cytopathic Effect (CPE) | Morphological changes in infected cells | Cell rounding → HSV; syncytia formation → RSV, measles; inclusion bodies → CMV (owl-eye) |
| Hemadsorption | Viral hemagglutinin on cell surface binds RBCs added to culture | Influenza, Parainfluenza, Mumps |
| Plaques | Clear areas in cell monolayer (cells killed by virus) | Poliovirus, HSV, VSV; counted as PFU |
| Interference | Virus grows but no CPE; detected by inhibiting 2nd indicator virus | Rubella (classic) |
| Transformation | Normal cells become immortalized | EBV, HPV, SV40 |
Viral Quantitation Methods:
- TCID₅₀ (Tissue Culture Infective Dose₅₀) = dilution at which 50% of inoculated cultures show CPE; calculated by Reed-Muench method
- PFU (Plaque-Forming Units) = number of plaques per mL = infectious virus particles
Applications of Tissue Culture:
| Application | Details |
|---|
| Viral isolation & diagnosis | Gold standard for HSV, CMV, enteroviruses, adenoviruses |
| Vaccine production | Poliovirus (Salk/Sabin), MMR, Varicella, Rabies (VERO cell-based) |
| Antiviral drug testing | IC₅₀ determination; resistance testing |
| Virus quantification | TCID₅₀, PFU |
| Viral pathogenesis research | CPE characterization; receptor studies |
| Production of biologicals | Interferon, monoclonal antibodies, recombinant proteins |
| Cancer research | Oncovirus-cell interactions |
QUICK REVISION TABLE — ALL 15 FIVE-STAR TOPICS
| Q | Topic | 3-Line Rapid Recall |
|---|
| 1 | Koch's Postulates | 4 criteria: present in disease → pure culture → reproduce disease → re-isolate. Classic: TB, anthrax. Limitations: obligate intracellular, carriers, ethics |
| 4 | Dark-Field Microscope | Oblique light; bright objects on dark background; detects 0.02 µm organisms; T. pallidum (syphilis diagnosis - gold standard before serology) |
| 5 | Gram+ vs Gram- Wall | G+: thick PG, teichoic acids, no OM; G-: thin PG, outer membrane with LPS, periplasm, porins; Staph vs E. coli |
| 7 | Bacterial Capsule | Polysaccharide (except B. anthracis = poly-D-Glu); anti-phagocytic; demonstrated by India ink/Quellung; K antigen; vaccines |
| 8 | Bacterial Spores | Ca²⁺-dipicolinate; Schaeffer-Fulton stain (green); C. tetani = drumstick; C. botulinum = subterminal oval; resistant to boiling |
| 9 | Growth Curve | Lag → Log → Stationary → Death; binary fission; N = N₀ × 2ⁿ; E. coli = 20 min; MTB = 14–20 h |
| 12 | Anaerobic Culture | GasPak jar, glove box, Bio-bag; CCFA for C. diff; BBE for Bacteroides; thioglycollate broth; hold 5–7 days |
| 15 | AST Classification | Disc diffusion (qualitative), MIC/E-test (quantitative), PCR (molecular); S/I/R per CLSI; MIC = lowest conc. inhibiting growth |
| 17 | PCR | Denature (95°C) → Anneal (50–65°C) → Extend (72°C); 30 cycles = 10⁶× amplification; RT-PCR (RNA viruses), qPCR (viral load) |
| 18 | Transduction | Phage transfers DNA; Generalized = any gene (P1 phage); Specialized = adjacent genes (λ phage); cholera toxin, diphtheria toxin = phage-encoded |
| 19 | Conjugation | Sex pilus; F plasmid; rolling circle replication; Hfr/F⁺/F'; primary mechanism of R-plasmid/MDR spread |
| 20 | Drug Resistance | 3 mechanisms: (1) Reduced accumulation (porins, efflux); (2) Target alteration (PBP2a-MRSA, D-Ala-D-Lac-VRE); (3) Enzymatic inactivation (β-lactamase, ESBL, carbapenemase) |
| 21 | Exo vs Endotoxin | Exo = protein, heat-labile, toxoid possible, highly toxic; Endo = LPS, heat-stable, no toxoid, causes septic shock via TLR-4/TNF cascade |
| 22 | Viral Lab Diagnosis | Specimen → DFA/Ag detection → Culture (CPE/hemadsorption) → Serology (IgM acute; WB HIV) → PCR (most sensitive); qPCR for viral load |
| 23 | Tissue Culture | Primary (PMK) / Diploid (MRC-5, WI-38) / Continuous (Vero, HEp-2, MDCK); Evidence: CPE, hemadsorption, plaques; Applications: vaccine, antiviral testing, diagnosis |
Good luck tomorrow! Focus especially on the comparison tables (Q5, Q21) and the mechanism diagrams for Q17 (PCR), Q18 (Transduction), Q19 (Conjugation) and Q20 (Drug Resistance) - examiners love asking for these in 5-mark answers.